Shares of Moderna Inc. /zigman2/quotes/205619834/composite MRNA +0.48% rallied 2.32% to $120.99 Monday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index /zigman2/quotes/210598365/realtime COMP -0.18% rising 2.27% to 10,815.43 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +0.10% rising 2.66% to 29,490.89. This was the stock's second consecutive day of gains. Moderna Inc. closed $255.66 short of its 52-week high ($376.65), which the company reached on November 29th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as AbbVie Inc. /zigman2/quotes/202428675/composite ABBV +1.26% rose 3.06% to $138.32, Amgen Inc. /zigman2/quotes/209157011/composite AMGN -0.15% rose 2.24% to $230.44, and AstraZeneca PLC ADR /zigman2/quotes/200304487/composite AZN +0.19% rose 1.29% to $55.55. Trading volume (3.8 M) remained 1.0 million below its 50-day average volume of 4.8 M.